Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature
Andreas Pinter,1 Henrik Thormann,2 Flavia Angeletti,1 Ahmad Jalili3 1Department of Dermatology, Venereology, and Allergology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany; 2Dermatology Clinic, Vejle, Denmark; 3Department of Dermatology, Bürgenstock Medical Center, Obb&a...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-10-01
|
| Series: | Clinical, Cosmetic and Investigational Dermatology |
| Subjects: | |
| Online Access: | https://www.dovepress.com/calcipotriolbetamethasone-dipropionate-aerosol-foam-for-the-treatment--peer-reviewed-article-CCID |
| _version_ | 1811283729831690240 |
|---|---|
| author | Pinter A Thormann H Angeletti F Jalili A |
| author_facet | Pinter A Thormann H Angeletti F Jalili A |
| author_sort | Pinter A |
| collection | DOAJ |
| description | Andreas Pinter,1 Henrik Thormann,2 Flavia Angeletti,1 Ahmad Jalili3 1Department of Dermatology, Venereology, and Allergology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany; 2Dermatology Clinic, Vejle, Denmark; 3Department of Dermatology, Bürgenstock Medical Center, Obbürgen, Switzerland Abstract: An aerosol foam formulation of a once-daily, fixed-dose combination of a synthetic vitamin D3 analog/synthetic corticosteroid (calcipotriol [Cal] 50 µg/g and betamethasone dipropionate [BD] 0.5 mg/g) has recently been introduced for the topical treatment of plaque psoriasis in adults. Data from several sources – randomized controlled trials, case reports (as highlighted in this review), and real-world evidence (RWE) – underscore the considerable and rapid clinical response, effectiveness, and favorable safety and tolerability of Cal/BD aerosol foam in mild-to-moderate psoriatic patients previously treated with class 3 or 4 topical corticosteroids, in patients unsatisfied with ongoing phototherapy in combination with topical therapy and in patients with moderate-to-severe psoriasis. In addition, our case series, considered together with other RWE, highlights that Cal/BD aerosol foam is more effective and with greater levels of patient preference and acceptability than comparator preparations. Thus, Cal/BD aerosol foam offers several treatment advantages, including relief of itch, and is an appropriate first-line topical therapy for consideration in patients with psoriasis of any severity. Keywords: aerosol, betamethasone dipropionate, calcipotriol, psoriasis |
| first_indexed | 2024-04-13T02:17:50Z |
| format | Article |
| id | doaj.art-38f40450ab244da3b0ae6636ae622c94 |
| institution | Directory Open Access Journal |
| issn | 1178-7015 |
| language | English |
| last_indexed | 2024-04-13T02:17:50Z |
| publishDate | 2018-10-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Clinical, Cosmetic and Investigational Dermatology |
| spelling | doaj.art-38f40450ab244da3b0ae6636ae622c942022-12-22T03:07:06ZengDove Medical PressClinical, Cosmetic and Investigational Dermatology1178-70152018-10-01Volume 1145145941273Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literaturePinter AThormann HAngeletti FJalili AAndreas Pinter,1 Henrik Thormann,2 Flavia Angeletti,1 Ahmad Jalili3 1Department of Dermatology, Venereology, and Allergology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany; 2Dermatology Clinic, Vejle, Denmark; 3Department of Dermatology, Bürgenstock Medical Center, Obbürgen, Switzerland Abstract: An aerosol foam formulation of a once-daily, fixed-dose combination of a synthetic vitamin D3 analog/synthetic corticosteroid (calcipotriol [Cal] 50 µg/g and betamethasone dipropionate [BD] 0.5 mg/g) has recently been introduced for the topical treatment of plaque psoriasis in adults. Data from several sources – randomized controlled trials, case reports (as highlighted in this review), and real-world evidence (RWE) – underscore the considerable and rapid clinical response, effectiveness, and favorable safety and tolerability of Cal/BD aerosol foam in mild-to-moderate psoriatic patients previously treated with class 3 or 4 topical corticosteroids, in patients unsatisfied with ongoing phototherapy in combination with topical therapy and in patients with moderate-to-severe psoriasis. In addition, our case series, considered together with other RWE, highlights that Cal/BD aerosol foam is more effective and with greater levels of patient preference and acceptability than comparator preparations. Thus, Cal/BD aerosol foam offers several treatment advantages, including relief of itch, and is an appropriate first-line topical therapy for consideration in patients with psoriasis of any severity. Keywords: aerosol, betamethasone dipropionate, calcipotriol, psoriasishttps://www.dovepress.com/calcipotriolbetamethasone-dipropionate-aerosol-foam-for-the-treatment--peer-reviewed-article-CCIDaerosolbetamethasone dipropionatecalcipotriolpsoriasis |
| spellingShingle | Pinter A Thormann H Angeletti F Jalili A Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature Clinical, Cosmetic and Investigational Dermatology aerosol betamethasone dipropionate calcipotriol psoriasis |
| title | Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature |
| title_full | Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature |
| title_fullStr | Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature |
| title_full_unstemmed | Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature |
| title_short | Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature |
| title_sort | calcipotriol betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris case series and review of the literature |
| topic | aerosol betamethasone dipropionate calcipotriol psoriasis |
| url | https://www.dovepress.com/calcipotriolbetamethasone-dipropionate-aerosol-foam-for-the-treatment--peer-reviewed-article-CCID |
| work_keys_str_mv | AT pintera calcipotriolbetamethasonedipropionateaerosolfoamforthetreatmentofpsoriasisvulgariscaseseriesandreviewoftheliterature AT thormannh calcipotriolbetamethasonedipropionateaerosolfoamforthetreatmentofpsoriasisvulgariscaseseriesandreviewoftheliterature AT angelettif calcipotriolbetamethasonedipropionateaerosolfoamforthetreatmentofpsoriasisvulgariscaseseriesandreviewoftheliterature AT jalilia calcipotriolbetamethasonedipropionateaerosolfoamforthetreatmentofpsoriasisvulgariscaseseriesandreviewoftheliterature |